State desk: new licenses in Georgia, pre-rolls in Delaware, a store cap fight in Washington

Five states moved on licensed cannabis this month, and most of the moves point the same way: regulators are adjusting who can sell what, and through which channel, rather than opening markets wholesale. Georgia will take medical dispensary license applications from 16 to 20 November as its patient registry heads towards 65,000. Delaware lets growers make their own pre-rolls from 11 November. Ohio processors can now turn packaged retail flower into concentrates.

Washington regulators are moving to close gaps that let retail groups run more than five stores, and Alabama's young medical market is about to reach five dispensaries. Each change shifts margins or access for a specific group of operators.

Georgia: patient growth unlocks more stores

Georgia's Access to Medical Cannabis Commission will accept dispensary license applications from 16 through 20 November, executive director Andrew Turnage announced at a commission meeting, The Marijuana Herald reported. It is the third window this autumn; the next regular one is in January 2027.

The trigger is patient numbers. State law gives each production licensee five dispensing licenses, plus one more once the patient registry reaches 25,000 and another for every 10,000 patients after that. At 65,000 patients, each of the state's six producers could hold up to 10 stores, or 60 statewide. Only existing producers can apply, and each license still needs commission approval.

The registry has grown fast since the Putting Georgia's Patients First Act took effect on 1 July. The law, Senate Bill 220, replaced the old 5% THC cap on products with a 12,000 mg possession limit, allowed vaporizable products for patients 21 and older, and added qualifying conditions including lupus, according to MJBizDaily. The Marijuana Herald reported 36,703 active patients at the end of June and 56,650 by 23 September. Turnage said he expected the 65,000 mark to be reached "very soon". For scale, WABE reported in late 2025 that a new Atlanta license brought the state's dispensary total to 19.

Delaware: growers can sell their own pre-rolls

Delaware's Office of the Marijuana Commissioner finalised amendments to its adult-use rules that let licensed cultivators make pre-rolls and sell them to licensed retailers without a separate manufacturing license. The rule was proposed on 1 September, comments closed on 1 October, and it takes effect on 11 November after publication in the state register.

The permission is narrow. Pre-rolls may contain only flower grown at the same facility and must carry the grower's own brand. Cultivators cannot make pre-rolls for other companies, buy in flower from other licensees for the purpose, or add concentrates or kief, so infused pre-rolls stay with manufacturers. Sales still run through licensed stores, with no direct-to-consumer channel.

Growers no longer need to ship flower to a manufacturer to get pre-rolls on shelves, and keep control of branding and wholesale terms. Manufacturers that roll for growers lose some demand.

Ohio: a release valve for packaged flower

Ohio's Division of Cannabis Control rule 1301:18-6-08, effective 2 November, lets licensed processors take flower that was already packaged for retail sale and extract it into bulk distillate, bulk extract or finished processed products. The conditions are strict: the flower must arrive undamaged and unadulterated, must have passed state testing, and must be fully extracted. Processors cannot simply repackage it in its original form, the resulting products must pass testing again before sale.

A companion rule, 1301:18-3-18, lets unopened, previously tested products move between cultivators, processors and dispensaries without retesting just because they changed hands. Together the rules give a path for slow-moving packaged flower on a dispensary shelf to go back to a processor and return as a vape or concentrate. Neither the rule nor the reporting puts a number on how much packaged flower is sitting unsold.

The common thread is inventory and control: regulators are letting product move more freely between license types while tightening who can control the shelf.

Washington: closing the five-store loopholes

Washington limits any person or company to an interest in no more than five retail licenses. A 2025 law, ESSB 5403, effective 1 January 2026, spelled out what counts as such an interest, including shared branding, websites and social media, coordinated purchasing and operational control. The Liquor and Cannabis Board's proposed rules, scheduled to go before the board on 4 November, would turn that into enforceable detail.

Under the CR-102 proposal, common use of trade names, logos or websites across licenses would count as a financial interest. Management and consulting deals could not give control over more than five stores and would have to be disclosed to the board before taking effect. Processors could no longer offer a retailer prices not available on the same basic terms to every retailer in the state, and exclusivity deals, including white-label products made only for one retailer, would be banned. New penalties would apply to anyone holding interests beyond the cap.

The rules answer small retailers' complaints: a 2025 petition from Greenside Recreational argued that larger buyers were taking whole lots at discounts smaller shops could not get, and board staff said the ESSB 5403 rulemaking would address it. The board puts the compliance cost per licensee at under $100; the real cost falls on groups that have built multi-store brands through licensing and management deals, which would need to restructure.

Alabama: a medical market starts to fill in

Alabama's medical program, authorized in 2021, did not see its first sale until 3 June, when Callie's Apothecary opened in Montgomery after years of licensing litigation, the Alabama Reflector reported. Officials said on 29 October that two more stores would open the following week, a third Callie's in Bessemer and a second Bama Bloom in Birmingham, bringing the statewide total to five.

The market is still small. Officials projected $130,000 to $140,000 in October revenue from the three stores then open, and more than 2,300 patient cards had been issued. Products are limited to forms such as tablets, oils and patches; smokable flower is banned. A fourth dispensary license is tied up at the Court of Civil Appeals, and integrated facility licenses that could lift the store count to 37 are also in litigation. Director John McMillan plans to retire; a committee seeking his successor reports in December.

What to watch

Delaware's pre-roll rule takes effect on 11 November. Georgia's window runs 16 to 20 November, and the number of producers that apply will signal how quickly the store count can rise. In Washington, the public hearing and the end of comments fall on 10 December, with adoption possible from 6 January 2027 and rules in force around 6 February if the board approves the proposal. In Alabama, watch the appeals court ruling on the fourth dispensary license and the commission's December meeting.